Hints and tips:
Related Special Reports
...Clips from Illumina Inc / Seeking Alpha, Yahoo For further reading: Carl Icahn takes aim at genome sequencer Illumina over Grail deal Has Illumina taken the wrong path in its Grail quest?...
DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators
...The phase 3 trial is being led by Eisai, a Tokyo-based pharmaceutical company that has partnered US biotech Biogen to develop lecanemab....
...A version of this article was first published by Nikkei Asia on April 5 2022. ©2022 Nikkei Inc....
...A version of this article was first published by Nikkei Asia on December 23, 2021. ©2021 Nikkei Inc....
...There was also a V-shaped neck pillow and a sort of snake-like one that reminded me of something I used during the latter stages of pregnancy....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Meanwhile, the three-decade quest for a malaria vaccine continues along more mundane — and less lucrative — lines for the industry....
...Shares in Vectura, whose clients include GlaxoSmithKline and Hikma Pharmaceuticals, closed up 14 per cent at 155p....
...His vice-president, Delcy Rodríguez, had just arrived back from Moscow bearing seasonal tidings of comfort and joy regarding Russia’s Sputnik V vaccine....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Regeneron Pharmaceuticals has been the top performer with a 10.4 per cent rise, as the company races to develop treatments for coronavirus....
...Immortality, Inc. , by Chip Walter, National Geographic Partners, RRP £17.99...
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...When Andy Conrad spun Verily out of Google’s secretive research facility, X, he declared that the newly formed life sciences unit of Alphabet was on a quest to “defeat mother nature” — through “truth”....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...Ms Holmes based Theranos on her quest for an alternative to venous draws of blood using a needle....
...The quest to expand the benefits of cancer immunotherapy to more patients suffered a big setback on Friday following the failure of a closely followed clinical trial....
...Big pharmaceutical companies are always in a wearying quest for the next blockbuster drug, which makes them prone to regulatory whim, cost-cutting buyers, and rival producers of generic compounds....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
International Edition